We additionally investigated spike-specific CD4+ and CD8+ T-cell responses in a subset of 24 individuals, including 8 older adults, who subsequently experienced their first SARS-CoV-2 breakthrough infection between 1 and 6 months after receiving 3 vaccine doses. This evidence concerns the gene CD4 and infection.